Preferences for Risks and Benefits of Islet Cell Transplantation for Persons With Type 1 Diabetes With History of Episodes of Severe Hypoglycemia: A Discrete-Choice Experiment to Inform Regulatory Decisions-Reference-Cited by-同舟云学术

Preferences for Risks and Benefits of Islet Cell Transplantation for Persons With Type 1 Diabetes With History of Episodes of Severe Hypoglycemia: A Discrete-Choice Experiment to Inform Regulatory Decisions

Published:2022-06-03 Issue:8 Volume:106 Page:e368-e379
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Wilson Leslie,Kwok Tiffany,Ma Yanlei,Wong Jenise,Ho Martin,Ionova Yelena,McGrath Maureen,Mueller Monica M.,Gitelman Stephen E.,Irony Telba

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference46 articles.

1. Management strategies for brittle diabetes.;Vantyghem;Ann Endocrinol (Paris),2006

2. Pancreas transplantation in diabetic humans normalizes hepatic glucose production during hypoglycemia.;Barrou;Diabetes,1994

3. Pancreas transplantation restores epinephrine response and symptom recognition during hypoglycemia in patients with long-standing type I diabetes and autonomic neuropathy.;Kendall;Diabetes,1997

4. Hypoglycemia after successful pancreas transplantation in type I diabetic patients.;Cottrell;Diabetes Care,1991

5. Steroid avoidance versus steroid withdrawal after simultaneous pancreas-kidney transplantation.;Cantarovich;Am J Transplant,2005

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐term effects of pancreatic islet transplantation on polyneuropathy in patients with brittle diabetes: A single‐center experience;Muscle & Nerve;2023-07-13

2. Prosthesis preferences for those with upper limb loss: Discrete choice study of PULLTY® for use in regulatory decisions;Journal of Rehabilitation and Assistive Technologies Engineering;2023-01

3. Generation of glucose sensitive insulin‐secreting cells from human induced pluripotent stem cells on optimized polyethersulfone hybrid nanofibrous scaffold;Artificial Organs;2022-11-04